Meibomian gland dysfunction, or MGD, is one of the most common causes of an abnormal tear film lipid layer and evaporative dry eye, with numerous risk factors reported. Its prevalence varies among ...

Label expansion for evaporative dry eye due to MGD will support further efforts to drive patient access to insurance-covered TearCare treatments MENLO PARK, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- ...

Please provide your email address to receive an email when new articles are posted on . With the exception of the eventual, however begrudging, acceptance of dry eye disease as a thing, the biggest ...

A systematic review found that there were currently a limited number of clinical trials evaluating treatment for dry eye disease (DED) that is associated with meibomian gland dysfunction (MGD). Future ...

Lid margin collarettes are common in moderate-to-severe DED, but most do not progress over time. No link was found between ...

Dry eye disease (DED) affects nearly 16 million Americans. This multifactorial condition, characterized by rapid tear evaporation or decreased tear production, can cause symptoms from eye irritation ...

The National Eye Institute, part of the National Institutes of Health, awarded Jason J. Nichols, OD, MPH, PhD, FAAO, a five-year, $1.9 million R01 grant to study potential molecular markers in ...

Deal expands access to TP-03 for approximately 40 million patients with Demodex blepharitis and 70 million patients with Meibomian Gland Disease in China, the world’s second largest healthcare market ...

The Business Research Company's Meibomian Gland Dysfunction Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – ...

MENLO PARK, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing ...